Fri, Aug 1, 2014, 11:34 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Rockwell Medical, Inc. Message Board

bfhdogs52 7 posts  |  Last Activity: Jul 15, 2014 12:33 PM Member since: Mar 25, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • bfhdogs52 by bfhdogs52 May 13, 2014 2:13 PM Flag

    1st qtr. missed estimates, even with $2.2M NDA fee. Nothing of any significance will be happening until Calcitriol approval which is guided for 2nd half of year and who knows if that will hold up. Triferic not until next year sometime. No catalyst for stock to go up for quite some time. Wall Street obviously was not impressed with 1st qtr. numbers.

    Sentiment: Sell

  • bfhdogs52 by bfhdogs52 May 14, 2014 12:51 PM Flag

    I have been long in the stock for a long time and just sold out my position. I believe the company will do very well when Triferic is approved by FDA but meantime there is little to no catalyst for the stock price. Calcitriol may be approved in the 2nd half of this year but that's about it as far as any significant news is concerned. I'll keep a close eye on the stock and may buy back in when it finally bottoms. Good luck to you longs. It will pay off but you will have to wait a year.

  • Reply to

    Fantastic outlook and statement

    by mkiss777777 May 14, 2014 1:06 PM
    bfhdogs52 bfhdogs52 May 14, 2014 4:32 PM Flag

    My comment on this is you need to talk to Life-Sci about their take on these comments by Chioini. They believe these comments do not signal anything new but simply a re-statement of what has been going on and a deal of any kind is very unlikely this year. I think the stock is dead money until 2015 when FDA approval is expected.

  • Reply to

    Low Cash

    by inngol2005 May 13, 2014 7:38 PM
    bfhdogs52 bfhdogs52 May 14, 2014 4:34 PM Flag

    Agree. Triferic will VERY likely be approved.

  • Reply to

    Fantastic outlook and statement

    by mkiss777777 May 14, 2014 1:06 PM
    bfhdogs52 bfhdogs52 May 15, 2014 8:44 AM Flag


  • bfhdogs52 by bfhdogs52 May 29, 2014 1:03 PM Flag

    Unless some large investors form the institutional presentation decide to buy very soon, the stock will likely retreat from these levels. FDA acception of Triferic is great news but was expected. I don't see any other catalysts this year to propel the stock upward.

    Sentiment: Sell

  • bfhdogs52 by bfhdogs52 Jul 15, 2014 12:33 PM Flag

    Stock has no reason to go up and will go down as the market starts to deteriorate. Can't fight the tape unless you have some exceptional news. Earnings will have no positive impact on the stock. Only Triferic approval or a joint venture would provide an impetus and both are next year events. May be a reasonable buy at 8-9. Puts may also be a good option if you can get them.

    Sentiment: Strong Sell

10.44+0.34(+3.37%)Aug 1 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.